...

HEALTHCARE

Touching every stage of human health, leading marketing and sales force in the pharmaceutical sector.

A continually growing portfolio of products and services ranging from preventive care to early detection, innovative treatments, and individual care.

0

PRODUCTION PLANTS

+0

EMPLOYEES

0

YEARS' EXPERIENCE

+0

EXPORT MARKETS

0

INTERNATIONAL COOPERATION AGREEMENTS

Since 1942, when Dr. Nejat F. Eczacıbaşı began to produce D-Vital, a vitamin compound he developed in his own laboratory, the Eczacıbaşı Group's healthcare operations have been at the vanguard of an integrated approach to healthcare in Turkey with a continually expanding portfolio. Eczacıbaşı established Turkey’s first modern pharmaceutical plant in 1952, and over the next half century contributed to the development of Turkey's pharmaceutical and active ingredient industries. In 2007, the Eczacıbaşı Group transferred its manufacturing operations to Zentiva and expanded into new product and service fields. In line with this growth strategy, Eczacıbaşı is strengthening its presence in nuclear medicine while continuing to offer products that target good health and treat chronic diseases.

Going forward, Eczacıbaşı's healthcare business is turning its focus to products manufactured with advanced technology. It aims to apply the know-how and experience of its joint venture partners, world leaders in R&D, to its own production, marketing and sales processes so as to reinforce its mission of providing modern, high quality and healthy products and services. With its steadily growing portfolio serving each stage of human health and its respective needs – from preventative care to early detection, advanced treatments to personalized care – Eczacıbaşı's healthcare business is pioneering the integrative care approach in Turkey.

...

Eczacıbaşı Pharmaceutical Marketing

Eczacıbaşı Pharmaceutical Marketing

One of Turkey’s most prestigious pharmaceutical marketing and sales companies, Eczacıbaşı Pharmaceutical Marketing carries out the marketing, promotion, sales and distribution of both imported and contract manufactured pharmaceuticals and non-prescription products. The company conducts its sales operations from six main regional offices and collaborates with 17 licensing firms on over 140 products (including dosage forms) used in 30 treatment areas. With regard to R&D, the company is engaged in a constant information exchange with the world’s leading international pharmaceutical companies.

Corporate Profile

General Manager

Başbuğ Öke

Address

Büyükdere Cad. Ali Kaya Sok. No: 5 34394 Levent, İstanbul

Website

www.eip.com.tr

...

Eczacıbaşı Monrol Nuclear Products

Eczacıbaşı Monrol Nuclear Products

Established in 1985 by Bozlu Holding, Eczacıbaşı Monrol Nuclear Products became a joint venture with Eczacıbaşı Pharmaceutical and Industrial Investment in 2008. Since its foundation, the company has pioneered the development of nuclear medicine in Turkey and expanded its radiopharmaceutical production while ensuring the highest standards of product and service quality in its field. Eczacıbaşı Montrol is the first Turkish manufacturing company serving nuclear medicine centers both at home and abroad. It employs over 250 specialists at its four plants in Turkey (Gebze, Adana, Izmir, Istanbul) and three international plants (Romania, Bulgaria and Egypt) to produce a large portfolio of products (PET, SPECT, Teranostic, API&PET Sets). also manages 6 cyclotron facilities in Kuwait, Dubai, Erbil, Pakistan and Ankara.

Corporate Profile

General Manager

Mustafa Aydın Küçük

Address

Rüzgarlıbahçe Mahallesi, Kavak Sokak, No:20 Kat:8 34805 Beykoz / İstanbul

...

Gensenta

Gensenta

Gensenta, which has been serving public health for nearly a century, became one of the companies of the Eczacıbaşı Group in November 2022. With a specialized workforce of approximately 600 people and modern facilities, Gensenta is one of Türkiye's leading manufacturers of finished pharmaceuticals and pharmaceutical raw materials. At its Raw Material Production Facilities, four independent production units manufacture penicillin group active pharmaceutical ingredients, macrolide group active pharmaceutical ingredients, as well as Etodolac and other active pharmaceutical ingredients. Gensenta produces medicines in compliance with world-class "Current Good Manufacturing Practices (cGMP)" and "Current Good Laboratory Practices (cGLP)" rules, continuously offering training, knowledge accumulation, and modern technology. Its products and innovative, comprehensive solutions are provided for human health in many countries, both domestically and internationally.